| Catalog Number |
305167 |
| Medical Device Problem Code |
Complete Blockage (1094)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
11/18/2024
|
|
Type of Reportable Event
|
Malfunction
|
|
Event or Problem Description
|
|
No additional information received.
|
| |
|
Additional Manufacturer Narrative
|
|
(b)(4) follow up: a device history record review was completed by our quality engineer team for provided material number 305167 and lot number 2279031.The review did not reveal any detected abnormalities during the production process that could have contributed to this defect and all quality tests were found to be within specification.As a sample was unavailable for return, a thorough sample investigation could not be completed.Based on the investigation results, an exact cause for this incident could not be identified.Should you again experience any problems with our product we would appreciate the opportunity to conduct a thorough analysis.There are quality controls currently in place to detect this type of defect during the production process.Further action has not been determined necessary at this time.
|
| |
|
Event or Problem Description
|
|
Materials: 305167, batch#: 2279031.Verbatim: rcc received a complaint via email.I represent the at and we were instructed by one of our sponsors to report that we experienced clogging of a 21g 1*1/2in needle when attempting to administer a medication composed of microparticles.I do not have a po for these needles ref (b)(4), lot 2279031.Additional information: event occurred on (b)(6) 2024.Outcome was only a portion of the dose injected.No ae or injury reported.
|
| |
|
Additional Manufacturer Narrative
|
|
Initial mdr submission.A follow up mdr will be submitted if additional information, a device evaluation, or a device history review is completed.
|
| |
|
Event or Problem Description
|
|
No additional information.
|
| |
|
Additional Manufacturer Narrative
|
|
Becton dickinson and company's (bd) medication delivery solutions (mds) business unit will discontinue malfunction mdr reporting for certain device failures that have not caused or contributed to deaths or serious injuries in the past two years, and where the likelihood of a death or serious injury as a result of these malfunctions is remote.This decision follows fda guidelines (medical device reporting for manufacturers guidance for industry and food and drug administration staff issued nov 8, 2016, reference section 2.15).Bd notified fda of this decision on mar 3, 2025.Fda has reviewed and responded to bd¿s notification (reference fda document#: (b)(4) on march 7, 2025.This documentation is available in bd document management system (sap) as (b)(4).This supplemental mdr is being filed to document that the below device failure will no longer be considered a reportable malfunction mdr for the product family below: product family: conventional needles.Device failure: needle clogged/blocked.
|
| |
|
Search Alerts/Recalls
|